I should have gone back to first principles. Gen AI does not think. It re-assembles content that was already produced by humans (which it often has taken without permission or compensation). This is why it needs to be “t…
Read in context ›Pfizer Stock (PFE)
Track Pfizer stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
PFE
Pfizer
healthcare
At close
$28.28
▲ +0.46 (+1.65%)
Oct 9, 4:01 PM ET
After-hours
$28.27
▼ -0.01 (-0.05%)
Oct 9, 7:59 PM ET
Market Cap
$158.56B
P/E Ratio
37.2x
1Y Return
+19.93%
EPS (TTM)
$0.76
Read the latest TheStreet Pro articles mentioning Pfizer, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
97 articlesDaily Diary Mentions
5 mentionsMore Tales From Nvidia: Hypothesis Creep and No Miracles (Issue #156!) More Tales From Nvidia: Just Like Moderna and Covid, AI Is Overdone Apropos to my Moderna post from this morning. Moderna MRNA was the bell of the ball 3-4 years ago, just like AI is now. Back then I was screaming about Moderna's share price (and, to some degree, its efficacy) like I am…
Read in context ›Subscriber Comment of the Day From SoCalGary: For fun, I asked I asked ChatGPT what to invest in with a couple of Doug's Surprises. #7: AI related equities are adversely impacted by two factors - the inadequacy of supply of electricity and the absenc…
Read in context ›Sic Transit Gloria Pfizer PFE is a favorite of Fin TV panelists, value investors and activists: https://twitter.com/Barchart/status/1859438643250635043 I continue to see it as a value trap.
Read in context ›Taking a Pass on Pfizer I spent several hours on Pfizer PFE over the weekend and for the life of me I can't understand what the activists see in this name. I will take a pass.
Read in context ›